File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.6004/jnccn.2012.0130
- Scopus: eid_2-s2.0-84870996017
- PMID: 23054877
- WOS: WOS:000309901900007
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Non-small cell lung cancer: Clinical practice guidelines in oncology
Title | Non-small cell lung cancer: Clinical practice guidelines in oncology |
---|---|
Authors | Ettinger, David S.Akerley, WallaceBorghaei, HosseinChang, Andrew C.Cheney, Richard T.Chirieac, Lucian R.D'Amico, Thomas A.Demmy, Todd L.Ganti, Apar Kishor P.Govindan, RamaswamyGrannis, Frederic W.Horn, LeoraJahan, Thierry M.Jahanzeb, MohammadKessinger, AnneKomaki, RitsukoKong, Feng MingKris, Mark G.Krug, Lee M.Lennes, Inga T.Loo, Billy W.Martins, RenatoO'Malley, JanisOsarogiagbon, Raymond U.Otterson, Gregory A.Patel, Jyoti D.Pinder-Schenck, Mary C.Pisters, Katherine M.Reckamp, KarenRiely, Gregory J.Rohren, EricSwanson, Scott J.Wood, Douglas E.Yang, Stephen C.Hughes, MirandaGregory, Kristina M. |
Issue Date | 2012 |
Citation | JNCCN Journal of the National Comprehensive Cancer Network, 2012, v. 10, n. 10, p. 1236-1271 How to Cite? |
Abstract | Most patients with non-small cell lung cancer (NSCLC) are diagnosed with advanced cancer. These guidelines only include information about stage IV NSCLC. Patients with widespread metastatic disease (stage IV) are candidates for systemic therapy, clinical trials, and/or palliative treatment. The goal is to identify patients with metastatic disease before initiating aggressive treatment, thus sparing these patients from unnecessary futile treatment. If metastatic disease is discovered during surgery, then extensive surgery is often aborted. Decisions about treatment should be based on multidisciplinary discussion. © JNCCN-Journal of the National Comprehensive Cancer Network. |
Persistent Identifier | http://hdl.handle.net/10722/266948 |
ISSN | 2023 Impact Factor: 14.8 2023 SCImago Journal Rankings: 4.102 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ettinger, David S. | - |
dc.contributor.author | Akerley, Wallace | - |
dc.contributor.author | Borghaei, Hossein | - |
dc.contributor.author | Chang, Andrew C. | - |
dc.contributor.author | Cheney, Richard T. | - |
dc.contributor.author | Chirieac, Lucian R. | - |
dc.contributor.author | D'Amico, Thomas A. | - |
dc.contributor.author | Demmy, Todd L. | - |
dc.contributor.author | Ganti, Apar Kishor P. | - |
dc.contributor.author | Govindan, Ramaswamy | - |
dc.contributor.author | Grannis, Frederic W. | - |
dc.contributor.author | Horn, Leora | - |
dc.contributor.author | Jahan, Thierry M. | - |
dc.contributor.author | Jahanzeb, Mohammad | - |
dc.contributor.author | Kessinger, Anne | - |
dc.contributor.author | Komaki, Ritsuko | - |
dc.contributor.author | Kong, Feng Ming | - |
dc.contributor.author | Kris, Mark G. | - |
dc.contributor.author | Krug, Lee M. | - |
dc.contributor.author | Lennes, Inga T. | - |
dc.contributor.author | Loo, Billy W. | - |
dc.contributor.author | Martins, Renato | - |
dc.contributor.author | O'Malley, Janis | - |
dc.contributor.author | Osarogiagbon, Raymond U. | - |
dc.contributor.author | Otterson, Gregory A. | - |
dc.contributor.author | Patel, Jyoti D. | - |
dc.contributor.author | Pinder-Schenck, Mary C. | - |
dc.contributor.author | Pisters, Katherine M. | - |
dc.contributor.author | Reckamp, Karen | - |
dc.contributor.author | Riely, Gregory J. | - |
dc.contributor.author | Rohren, Eric | - |
dc.contributor.author | Swanson, Scott J. | - |
dc.contributor.author | Wood, Douglas E. | - |
dc.contributor.author | Yang, Stephen C. | - |
dc.contributor.author | Hughes, Miranda | - |
dc.contributor.author | Gregory, Kristina M. | - |
dc.date.accessioned | 2019-01-31T07:20:04Z | - |
dc.date.available | 2019-01-31T07:20:04Z | - |
dc.date.issued | 2012 | - |
dc.identifier.citation | JNCCN Journal of the National Comprehensive Cancer Network, 2012, v. 10, n. 10, p. 1236-1271 | - |
dc.identifier.issn | 1540-1405 | - |
dc.identifier.uri | http://hdl.handle.net/10722/266948 | - |
dc.description.abstract | Most patients with non-small cell lung cancer (NSCLC) are diagnosed with advanced cancer. These guidelines only include information about stage IV NSCLC. Patients with widespread metastatic disease (stage IV) are candidates for systemic therapy, clinical trials, and/or palliative treatment. The goal is to identify patients with metastatic disease before initiating aggressive treatment, thus sparing these patients from unnecessary futile treatment. If metastatic disease is discovered during surgery, then extensive surgery is often aborted. Decisions about treatment should be based on multidisciplinary discussion. © JNCCN-Journal of the National Comprehensive Cancer Network. | - |
dc.language | eng | - |
dc.relation.ispartof | JNCCN Journal of the National Comprehensive Cancer Network | - |
dc.title | Non-small cell lung cancer: Clinical practice guidelines in oncology | - |
dc.type | Article | - |
dc.description.nature | link_to_OA_fulltext | - |
dc.identifier.doi | 10.6004/jnccn.2012.0130 | - |
dc.identifier.pmid | 23054877 | - |
dc.identifier.scopus | eid_2-s2.0-84870996017 | - |
dc.identifier.volume | 10 | - |
dc.identifier.issue | 10 | - |
dc.identifier.spage | 1236 | - |
dc.identifier.epage | 1271 | - |
dc.identifier.eissn | 1540-1413 | - |
dc.identifier.isi | WOS:000309901900007 | - |
dc.identifier.issnl | 1540-1405 | - |